In addition, patients with NAFLD and mutated PNPLA3 seem to have no response in terms of reduction of the novo lipogenesis and improvement in transaminases by n-3 PUFA supplementation in the diet [143]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.